[Perioperative management of multiorgan transplantation].
OBJECTIVE
To summarize the experience with perioperative management of multiorgan transplantation.


METHODS
From October 2001 to January 2005, 19 patients received multiorgan transplantation in Nanfang Hospital, including 6 with simultaneous kidney-pancreas transplantation (SKPT), 12 with combined liver-kidney transplantation (CLKT), and 1 with simultaneous liver-pancreas transplantation (SLPT). The surgical techniques, application of immunosuppressants, and complication management were reviewed.


RESULTS
All transplantation procedures were performed successfully. The transplantation-related complications included tacrolimus-induced renal toxicosis in 1 (5.3%) case, acute graft rejection in 3 (15.8%) cases, intestinal hemorrhage in 2 (10.5%) cases, intra-abdominal hemorrhage in 1 (5.3%) case, and lung infection in 1 (5.3%) case, all of which were cured after proper treatment.


CONCLUSIONS
Donor selection, good quality of the donor organ, proper surgical approaches, adequate use of the-mmunosuppressants, and prevention of complications are essential to the success of multiorgan transplantation.
Yu
Li-Xin
LX
Center of Organ Transplantation, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Ye
Jun-Sheng
JS
Deng
Wen-Feng
WF
Xu
Jian
J
Fu
Shao-Jie
SJ
Ye
Gui-Rong
GR
DU
Chuan-Fu
CF
Wang
Yi-Bin
YB
Liu
Xiao-You
XY
Miao
Yun
Y
D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000379:methods; D016031:Liver Transplantation / Q000379:methods; D008297:Male; D008875:Middle Aged; D016035:Pancreas Transplantation / Q000379:methods; D011182:Postoperative Care
D007166:Immunosuppressive Agents